tirzepatide in hfpef for Heart Failure Patients with Obesity Another "Positive" Heart Failure Trial
Pay in 4 interest-free payments of $7.28 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Live Spec
Another "Positive" Heart Failure Trial that Falls Short Impact of Body Mass Index, Central Adiposity, and Weight Loss on the Benefits of Tirzepatide in HFpEF: The SUMMIT Trial JACC Tirzepatide Reduces Heart Failure Events in HFpEF With Obesity At #ACC25, Dr. Milton Packer and colleagues present a new secondary analysis from the SUMMIT trial evaluating the effect of tirzepatide in patients with obesity, #HFpEF, and CKD. The trial demonstrated that # Tirzepatide and Cardiovascular Outcomes: A Narrative Review of Mechanisms, Efficacy and Implications for Heart Failure Management PMC
Store: live-language.pl · Domain: live-language.pl
























